We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+0.01%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.19B
AUM Growth
+$98.6M
Cap. Flow
-$41.7M
Cap. Flow %
-3.51%
Top 10 Hldgs %
21.68%
Holding
239
New
33
Increased
71
Reduced
43
Closed
41

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.74%
2 Technology 15.65%
3 Healthcare 15.5%
4 Consumer Staples 7.16%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETSY icon
76
Etsy
ETSY
$7.85B
$4.65M 0.39%
82,264
-17,474
-18% -$1.03M
IIPR icon
77
Innovative Industrial Properties
IIPR
$1.72B
$4.62M 0.39%
+49,985
New +$5.27M
GBT
78
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.58M 0.39%
94,363
+5,885
+7% +$307K
SNPS icon
79
Synopsys
SNPS
$79.7B
$4.52M 0.38%
+32,961
New +$4.46M
SPLK
80
DELISTED
Splunk Inc
SPLK
$4.51M 0.38%
38,265
-9,043
-19% -$1.13M
PHR icon
81
Phreesia
PHR
$773M
$4.48M 0.38%
+184,781
New +$4.87M
LULU icon
82
lululemon athletica
LULU
$14.6B
$4.47M 0.38%
23,218
COUP
83
DELISTED
Coupa Software Incorporated
COUP
$4.43M 0.37%
34,186
+120
+0.4% +$16.6K
RETA
84
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.42M 0.37%
54,991
+13,382
+32% +$1.14M
HAS icon
85
Hasbro
HAS
$13.2B
$4.34M 0.37%
+36,579
New +$4.17M
GWPH
86
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.32M 0.36%
37,524
+4,282
+13% +$650K
KEYS icon
87
Keysight
KEYS
$58.3B
$4.22M 0.35%
+43,367
New +$4.02M
SILK
88
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$4.2M 0.35%
129,196
+36,873
+40% +$1.47M
SRPT icon
89
Sarepta Therapeutics
SRPT
$1.77B
$4.18M 0.35%
55,523
+1,368
+3% +$162K
FSCT
90
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$4.15M 0.35%
109,386
-25,120
-19% -$918K
EHTH icon
91
eHealth
EHTH
$43.9M
$4.13M 0.35%
+61,812
New +$5.58M
NXRT
92
NexPoint Residential Trust
NXRT
$652M
$4.06M 0.34%
+86,912
New +$3.89M
TPTX
93
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$4.01M 0.34%
106,611
-279
-0.3% -$12.1K
TT icon
94
Trane Technologies
TT
$106B
$3.94M 0.33%
+32,008
New +$3.91M
VFC icon
95
VF Corp
VFC
$5.89B
$3.91M 0.33%
43,938
GTLS
96
DELISTED
Chart Industries
GTLS
$3.91M 0.33%
62,657
-771
-1% -$52.2K
QURE icon
97
uniQure
QURE
$3.22B
$3.89M 0.33%
98,909
+11,631
+13% +$671K
KRYS icon
98
Krystal Biotech
KRYS
$9.66B
$3.81M 0.32%
109,827
-402
-0.4% -$18K
KTB icon
99
Kontoor Brands
KTB
$4.26B
$3.76M 0.32%
+107,040
New +$3.47M
CLAR icon
100
Clarus
CLAR
$143M
$3.72M 0.31%
318,989
-2,869
-0.9% -$35.6K

Similar funds

Nicholas Investment Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Nicholas Investment Partners held 239 positions worth $1.19B, up 9% from $1.09B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nicholas Investment Partners withdrew a net $41.7M in Q3 2019, closing 41 positions and reducing 43 holdings. Its most notable exit was Pluralsight, Inc. Class A Common Stock, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Lattice Semiconductor worth $6.45M.

  • Nicholas Investment Partners's largest Q3 2019 buy was Lattice Semiconductor: 352,991 shares worth $6.45M.
  • Nicholas Investment Partners added most to Papa John's in Q3 2019, an estimated $7.07M increase.
  • Nicholas Investment Partners's biggest Q3 2019 reduction was Melco Resorts & Entertainment, cutting an estimated $8.79M.
  • Nicholas Investment Partners fully exited Pluralsight, Inc. Class A Common Stock in Q3 2019, selling an estimated $11.7M.
  • Nicholas Investment Partners's ten largest holdings make up 22% of its $1.19B portfolio in Q3 2019.
  • Nicholas Investment Partners opened 33 new positions and closed 41 in Q3 2019.
  • Nicholas Investment Partners's portfolio value rose 9% quarter-over-quarter to $1.19B.

Based on Nicholas Investment Partners's 13F filing for Q3 2019, filed 13 Nov 2019.